Silo Pharma Enhances Treasury Management with Fireblocks
Silo Pharma, Inc. (Nasdaq: SILO), a company diversifying into biopharmaceuticals and cryptocurrency treasury, has announced a pivotal step in its strategic direction. By collaborating with Fireblocks, a renowned platform for secure digital asset management, Silo aims to implement an advanced treasury management system that is both secure and efficient.
Fireblocks: A Leader in Digital Asset Security
Fireblocks stands out as a global leader in the digital assets realm, having safely facilitated the transfer of over $10 trillion. The company’s robust multi-layer security framework features groundbreaking technologies such as multi-party computation and Intel SGX. This guarantees a trusted custody solution, catering to the needs of institutional clients.
Expert Insight from Silo's CEO
Eric Weisblum, the CEO of Silo, expressed confidence in this partnership, stating, "Fireblocks brings unmatched expertise and a proven track record that will help Silo implement our treasury strategy. Collaboratively, we are constructing an institutional-grade infrastructure that provides the necessary technology to buy, stake, and manage digital assets at scale."
Strategic Focus and Developmental Goals
Silo Pharma remains dedicated to developing treatments that address unmet medical needs. Their therapeutic focus includes stress-induced psychiatric disorders, chronic pain, and various CNS diseases. With ongoing research initiatives conducted in partnership with leading universities and labs, the company is working on innovative programs targeting conditions such as PTSD and fibromyalgia.
Innovative Therapeutic Programs
The portfolio of Silo Pharma boasts a range of promising programs, including SPC-15 for PTSD and SP-26 aimed at fibromyalgia and chronic pain management. Additionally, its preclinical assets, which are in the pipeline, target neurodegenerative diseases like Alzheimer’s disease and multiple sclerosis. All of these efforts highlight Silo’s commitment to improving patient outcomes through groundbreaking research.
The Future of Silo Pharma
Looking ahead, Silo Pharma aims to expand its reach and enhance its ability to address complex health challenges. The partnership with Fireblocks is a strategic move that reflects their ambition to innovate within the cryptocurrency space while ensuring that all digital assets are managed with the highest level of security.
Contact Information for Investors
Silo encourages interested parties to get in touch for more information about its developments and partnerships. For inquiries, reach out at 800-705-0120 or via email at investors@silopharma.com.
Frequently Asked Questions
What is the significance of the partnership between Silo Pharma and Fireblocks?
This partnership enhances Silo's ability to manage its cryptocurrency treasury securely, facilitating robust operational structures.
What is Fireblocks known for?
Fireblocks is recognized for its leader status in digital asset security, having safely transferred over $10 trillion in assets.
What are Silo Pharma's primary therapeutic focuses?
Silo focuses on developing treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases.
What innovative programs are being developed by Silo Pharma?
Silo is working on programs for PTSD and fibromyalgia, as well as targeting Alzheimer’s disease and multiple sclerosis.
How can investors contact Silo Pharma for information?
Investors can contact Silo Pharma at 800-705-0120 or email investors@silopharma.com.
